Mark Cuban Cost Plus Drug Company, PBC
Making low cost versions of high cost generic drugs.
ActiveSummer 2018Other
About Mark Cuban Cost Plus Drug Company, PBC
Making low cost versions of high cost generic drugs.
Risk Analysis
Category Risk
22%death rate
Other: 130 of 604 startups failed
MEDIUMTeam Size
Team size data not available for this company.
External Resources
Read full post-mortem on startups.rip ↗(opens in new tab)Website ↗(opens in new tab)YC Profile ↗(opens in new tab)Report data issue
Post-mortem content hosted on startups.rip — we provide the analytics layer.